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IN 1832, Thomas Hodgkin (Major, 1932) delivered an address to the _Medico
Chirurgical Society of London on " Some morbid appearances of the absorbent
glands and spleen". Thirty-three years later, Wilks (Garrison, 1939) applied
the name Hodgkin's disease. Fox (1926) re-examined Hodgkin's original speci-
mens and found that of the seven cases described, three had Hodgkin's disease
as it is presently diagnosed, one tuberculosis, one syphilis, one systemic lympho-
matosis and one lymphosarcoma. Hodgkin's cases therefore, were a hetero-
geneous collection of disorders, although they did include his own disease.
Although some support an infective (Hoster, 1944) and others an immuno-
logical (Green, Inkelas, and Allen, 1960) aetiology, Hodgkin's disease today is
regarded by most pathologists as one of the malignant lymphoid tumours (Willis,
1960). Nowhere in pathology has a chaos of names so clouded clear concepts as
in the subject of lymphoid tumours. This confusion has resulted largely from
failure to recognize frankly certain intrinsic difficulties in the subject and to apply
certain general principles in their elucidation. The structural plasticity of
lymphoid tissue and its tumours gives the histopathologist great difficulty in
identifying early neoplasia, in differentiating between inflammatory or hyper-
plastic conditions and neoplasia, and in classifying this group of closely inter-
related tumours.
In this report the classification of Willis (1961) has been followed. He recog-
nizes four main types of malignant lymphoid tumour:
1. Follicular lymphoma.
2. Lymphosarcoma and lymphatic leukaemia.
3. Reticulum cell sarcoma.
4. Hodgkin's disease.
WVillis regards Hodgkin's disease as a tumour of primitive reticular cells in
which divergent differentiation of both lymphoid and fibroreticular elements
takes place. It is usual to subdivide Hodgkin's disease into three subgroups:
paragranuloma (benign Hodgkin's disease), granuloma (classical Hodgkin's
disease) and Hodgkin's sarcoma.
Originally described as " Early Hodgkin's disease " in 1937 (Jackson) a group
of cases resembling Hodgkin's disease but running a peculiarly benign course was
termed Hodgkin's paragranuloma by Jackson and Parker (1944). Harrison
(1952) agreed that this was a histological entity with a better prognosis than
Hodgkin's disease and suggested " Benign Hodgkin's disease " as a preferable
designation. Most cases diagnosed as Hodgkin's sarcoma should be classified
with reticulum cell sarcoma. This review is concerned only with classical
Hodgkin's disease and Hodgkin's paragranuloma.SURVIVAL IN HODGKIN S DISEASE
We have been most fortunate to have one pathologist, Dr. J. W. Whittick,
review most of the slides in this series. The majority of patients with reticulum
cell sarcoma in the Saskatchewain Cancer Clinics also have been reviewed in an
attempt to obtain a homogeneous series from a pathological stanidpoint. Dr.
Whittick has reminded us of Willis' observation (1960) that " No pathologist lives
long enough to become infallible in this (lymphoid tumour) field ".
The results of treatment in the majority of reported series of Hodgkin's
disease are difficult to interpret because of lack of knowledge of the selection
factors involved in the compilation of the series. An unselected series at times
seems to be a rather meaningless cliche indicating in many instances that the
collector has not voluntarily excluded any patients from his series but has little
if any knowledge of the involuntary and incidental factors of selection. Data
for most studies have been compiled from the experience of hospitals and clinics
in large medical centres. While experience of a relatively rare disease like Hodg-
kin's disease is concentrated at such centres, the number and magnitude offactors
of selection that influence the compilation of such a series are very difficult to
determine. To assemble data suitable for incidence studies (i.e. unselected) from
hospital statistics it is necessary either that all patients with the disease enter that
hospital, or that the number of patients with the disease who do and who do not
enter that hospital be known. Few hospitals can satisfy these criteria (Gilliam,
1953).
To collect an unselected series of patients with a particular disease, it is neces-
sary to define a geographic area and attempt to assemble information abouteach
case of that disease which has occurred among the residents of that area within a
specified period of time. If this is done it then becomes possible to obtain in-
formation about the incidence of the disease and to investigate features of the
disease in a series of patients who have not been selected in any way. In the
collection of this series of patients with Hodgkin's disease, these principles have
been observed.
METHODS
Three sources were used to ascertain the number of cases of Hodgkin's disease
in Saskatchewan between 1946 and 1956 (inclusive). The first of these was the
case records of the Saskatchewan Cancer Commission. This organization was
established by the provincial government in 1932 with the purpose of extending
a comprehensive diagnostic and treatment service for all the residents of the
province suffering from cancer and allied disorders. An individual is required to
have lived in Saskatchewan for a period of three months before he can be classed
as a resident. Clinics were established in Regina arid Saskatoon, the two largest
cities. Cancer services were made available free of charge to residents of the
province in 1944, but to obtain them it was required that the patients be referred
to or registered with the Cancer Clinics. The records of all patients in whom a
diagnosis of Hodgkin's disease had been made between 1946 and 1956 were with-
drawn for study.
Two other sources of information provided a means whereby the number of
patients with Hodgkin's disease not seen at the Cancer Clinics could be com-
puted. All death certificates issued in the province during the period under study
were examined and any bearing a diagnosis ofHodgkin's disease was cross-checked
with the Cancer Clinic records. If the patient had not been seen in either Cancer
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Clinic, information was sought from the hospitals and doctors concerned, and
the diagnosis was reassessed. Ifconfirmed, the case was included in the series and
assigned to the appropriate year.
By provincial law in Saskatchewan, any tissue removed at operation must
be submitted for pathological analysis. All pathology reports issued in the
province during the period under study were examined and any report indicating
a diagnosis of Hodgkin's disease was cross-checked with the Cancer Clinic and
death certificate files and included in the series if appropriate. The examination
of death certificates included those of patients normally resident in the province
who had died elsewhere in Canada. Any person not a resident of the province
was excluded.
RESULTS
The incidence of Hodgkin's disease in Saskatchewan from 1946 to 1960 was
found to be 1-62 per 100,000 per year and although features of the incidence of
the disease in Saskatchewan have been described elsewhere (Meighan, 1961), it
is necessary briefly to outline the constitution of this series. Eighty-one patients
were seen at the Regina Cancer Clinic and 64 at Saskatoon. Only 5 cases were
discovered by the survey of death certificates and pathology files. This means
that 96-7 per cent of the patients discovered to have Hodgkin's disease had been
seen in theCancer Clinics and stresses their value as a case recording agency. This
view is further supported by Watson (1950) who found that 85 per cent of all
cases of cancer in the province in 1948 had been referred to the Cancer Clinics;
also, 89 per cent of children with leukaemia between 1948 and 1960 had been
referred to the Cancer Clinics (Meighan, 1963).
In this series of 150 patients, none was lost to follow-up. Only six had
Hodgkin's paragranuloma, the remaining 144 having classical Hodgkin's disease.
There were 101 males and 49 females, giving a male to female ratio of 2-06: 1.
This ratio is not corrected for the slight excess of males over females in the popu-
lation. While these figures are in agreement with most other published reports
(Warwick and Sellars, 1959; Shimkin, Oppermann, Bostick and Low-Beer, 1955)
they have not been explained satisfactorily.
The age distribution shown in Fig. 1 shows the greatest number ofpatients were
in the 20-29 year age group. The median age was 35 years. These findings are
in agreement with most other published series (Warwick and Sellars, 1959;
Hoster, Dratman, Craver and Rolnick, 1948).
Age distribution, however, means little unless the age distribution of the
population from which the series is drawn is taken into account. In each age
group, if the number of cases is related to the number of individuals at risk a
different picture is obtained. It becomes apparent that the resulting age-
specific histogram is bimodal, with the probabilities of developing the disease
being greatest in young adulthood and older age (Fig. 2). Such bimodal age-
specific histograms are unusual and suggest either that different aetiological
mechanisms are operating at different periods of the age span, or that the disease
as it occurred in the two age groups most frequently affected might be in such a
fundamental area that it wouldnot seem appropriate to consider the condition as a
single disease (MacMahon, 1957).
Three stages of the disease were described by Peters (1960) and her classifica-
tion has been followed except that the absence of " symptoms of generalized
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disease " was not regarded as essential for patients in stage 1. This decision was
made in view of the difficulty encountered on some occasions, of determining
whether the patient's symptoms were due to Hodgkin's disease or to some other
coincidental condition. It also converted this staging to an entirely objective
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FIG. 2.-Age specific rates by ten-year age groups.
measure. Stage 1 is when lymph nodes are involved at one regional location,
stage 2, whenlymph nodes areinvolved atmore than one regional location butwith
no evidence ofdisease outwith the lymphatic system, and stage 3, when the disease
has become disseminated and such changes as splenic enlargement or anaemia
are present. In this series, 45 patients had stage 1 disease, 56 were in stage 2,
34 were in stage 3 and in 15 the stage could not be assessed from the evidence
available.28 S. S. MEIGHAN AND J. D. RAMSAY
It is of interest to note the very slight correlation between the stage of the
disease and the duration of the symptomatology (Table I). Although a pattern
TABLE I.-Stage and Duration of Symptoms
Duration of
symptoms
Less than 6 months
6 months to 1 year
Over 1 year
Total
Stage
I II
29 (28 0) 39 (34 8)
5 (8*0) . 10 (10*0)
11 (9-0) . 7 (11.2)
. 45 56
III
16 (21*2)
9 (6*0)
9 (6*8)
. 34
Total
84
24
27
. 135
Expected numbers in brackets.
Chi square = 7-174 4 df. 0 20 > p > 0 10.
The stage could not be determined from the data available in 15 patients.
is evident showing that stage 3 patients tend to have a longer duration of sympto-
matology than would be expected by chance, this difference does not reach a
statistically significant level. " Early " when applied to Hodgkin's disease prob-
ably is related more to the stage of the disease than to time.
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FIG. 3. Annual incidence of Hodgkin's disease in Saskatchewan, 1946-56.
Fig. 3 indicates that the disease is neither increasing or decreasing in frequency
in Saskatchewan during the period under study.
The clinical manifestations at the time of diagnosis of Hodgkin's disease have
been described previously (Meighan, 1961). The initial symptom was enlarge-
ment oflymph glands in 52 per cent of that series. The enlargement was usually
painless. Thirty-eight per cent had had symptoms for less than three months
and in 64 per cent the symptoms were of less than six months' duration. The
neck nodes were enlarged in 77 per cent, the axillary nodes in 41 per cent and the
mediastinal nodes in 29 per cent. The spleen was not enlarged in 78 per cent and a
haemoglobin ofless than 9 g. was present in only 8 per cent ofpatients at the time
of diagnosis.SURVIVAL IN HODGKIN S DISEASE
Having defined the constitution and the unselected nature of this series,
survival and the factors which influence it will now be considered. In this study,
survival was measured in completed months from the time of diagnosis or the
patient referred to the Cancer Clinics. The review period ended on December 31,
1961. If the patient was alive survival was measured to the time of the last
clinic visit. All patients who died were regarded as dying from Hodgkin's disease.
The three classic measures of central tendency mode, mean and median-
were considered in trying to arrive at the most meaningful index of survival.
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FIG. 4. Distribution by survival (three-month groups).
In estimating the mode of patient survival, it was found that there were
insufficient numbers in the present series to permit an analysis by single months,
but if the observations are arranged by three-month class intervals, a histogram
such as is shown in Fig. 4 is obtained. Deaths occur intermittently and during
most three-month periods. The commonest time for death to occur (the mode)
is 0-3 months after diagnosis. As the paucity of numbers necessitates using a
broad class-interval, the employment of the mode as an index of central tendency
in the present study has limited usefulness.
The mean or average survival can be measured in two ways. As the group of
patients who were diagnosed in 1956 have had the opportunity to survive for
only five years, and those diagnosed in 1946 the opportunity to survive 15 years,
it may be suggested that five years should be a cut-off time for estimating the
survival of all patients in the series, and the average calculated from these figures,
or, it may be suggested that the average should be calculated from the total
survival of all patients (e.g. including one patient diagnosed in 1946 who is still
alive). The mean survival was 30 6 months with a five-year cut-off time and 43-3
months if all the months survived are taken into account. The meaning of the
latter figure is obscure as several of the patients are still alive and therefore
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their final survival cannot be measured. The average of a group of numbers
cannot be calculated until all the numbers are known.
Survival in this series shows an asymmetrical distribution. The mean is aii
expressive symbol only in those distributions which have some semblance of
symmetry around a central axis. Such a distribution rarelv if ever, is seen ill
malignant disease, where a skewed distribution is usual, with the majority of
deaths occurring in the early period after diagnosis. A few patients survive for
relatively long periods of time and thereby exert an influence on the mean out
of proportion to their number. For this reason the mean survival is considered
to be a poor index for expressing longevity in Hodgkin's disease.
The five-year survival, the standard measure ofsurvival in neoplastic disorders,
has particular value in the assessment of survival in unicentric neoplasms and
mav indicate in manv instances that the patient who has survived for five years
has a reasonable expectation of being cured of his disease. In multicentric
neoplasms, however, the concept of cure rarely arises and as this is the usual
concept of the aetiology of Hodgkin's disease, the five-year survival figures have
lessened significance. In this series ofpatients 32 per cent survived for more than
from the time of diagnosis. Survival statistics from the majority of studies of
survival in Hodgkin's disease are expressed as the percentage surviving for five
vears.
When patients in a series are arranged in order of the length of time of their
survival, the median survival time is that time survived by the middle patient of
the series. If the median survival is less than five years, as it is in this series, it
will be unaffected by those patients who survive longer than five years and will
also be unaffected by those patients still alive five or more years after diagnosis.
For purposes of comparison we believe it to be the most useful single index of
survival. The median survival was 26-5 months. If the series is divided into
two groups-1946-50 and 1952-56, the median survival was found to be 32
months for the earlier and 22 months for the latter group. These figures would
seem to indicate the paucity of progress made in the treatment of Hodgkin's
disease during the period under study. Survival in a group ofpatients with Hodg-
kin's disease may also be shown as a time-survival graph (Fig. 5). This distribu-
tioin can be divided roughly into three parts. Approximately one-third of the
patients died in the first year, one-third survived for more than one but less than
five years, and approximately one-third survived five years or more.
The effect of sex on survival was studied by Epstein (1939) who observed that
the disease was not only less frequent but also less malignant in women than in
men. Warwick and Sellars (1959) showed that 2846 per cent of males survived
five years while 31-4 per cent of females survived for a similar period. Females
survived for longer periods than males in nearly all reported series, but in most the
difference was not recorded as being significant statistically. One exception how-
ever was the report by Hohl, Sarasin and Bessler (1951) who found a five-vear
survival of 18 per cent among 67 males and 42 per cent among sixty females.
In this study, females showed a longer survival than males; the median sur-
vival of 49 females was 41 months whereas for the 101 males it was 24 months. Of
the females 38-8 per cent survived for more than five years ; the comparable
figure for males was 26 7 per cent. This percentage difference does not amount to
twice the standard error of the difference of the two proportions however (it is
1-5 times as large), and cannot be regarded in itself as being of statistical signi-
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ficance. As many other series (Shimkin, Opperman, Bostick and Low-Beer,
1955; Peters, 1960; Epstein, 1939) record similar findings, it is probable that
the difference observed between the survival of males and the survival of females
in Hodgkin's disease is indeed a real one.
The effect of age on survival is always difficult to assess as the older the in-
dividual the shorter is his expectation oflife, even for those individuals apparently
without any disease. If a four-fold table is constructed, whereby the series is
divided into those below the median age (35 years), and those of the median age
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Fie. 5. Percentage of patients surviving by yearly intervals to 5 years.
or more, and likewise, on the other axis, those who survived less than the median
survival (for the purposes of calculation here approximated to 26 months), and
those who survived more than this interval, the table shown in Table II results.
The younger group survive longer than the older, and this to a statistically
significant degree (P < 0O001). This table permits one to say that a relationship
exists between survival in Hodgkin's disease and the age at onset.
TABLE II.-Survival in Certain Age Groups
Survival
Less than More than
Age 26 months 26 months
Less than . 23 . 50
35
More than . 51 . 26
35
In view of the difference in sex and survival and the possible influence of
endocrine factors, an attempt was made to relate survival with the sex and age
ofthe patient: 45 years ofage arbitrarily was chosen as being the time when many
women begin to undergo menopausal changes. The findings are shown in Table
III and indicate again that the young survive for longer periods than the old;
this difference is more pronounced in females than in males. Females-under 45
years have a better survival than their male counterparts. Females over the ageS. S. MEIGHAN AND J. D. RAMSAY
TABLE III.-Survival in Relation to Sex and Age
FEMALES
Survival
Less than More than
Age 26 months 26 months
Lessthan . 7 . 24
45
More than . 14 . 4
45
MALES
Survival
Less than More than
Age 26 months 26 months
Less than . 22 . 37
45
More than . 31 . 11
45
of 45 show a shorter survival than males ofa similar age. Although the numbers
in the various subcategories are too small to permit drawing any definite con-
clusions, such as they are, they further support the possibility that endocrine
factors may have a bearing on the question of survival.
When survival is related to the stage of the disease, a consistent correlation
can be obtained. The median survival in patients with stage 1 disease was 54
months, in stage 2, 36-5 months and in stage 3, 6 months. These figures support
the accuracy of staging as a prognostic indicator. The close correlation between
survival and splenic enlargement however indicates the importance ofthis finding
as regards the accuracy of the clinical staging. For those 111 patients in whom
no splenic enlargement was detected at the time of diagnosis the median survival
was 36months. Theedgeofthespleenwaspalpableadistancelessthan6 cm. below
theleft costal margin in 22 patients who had amedian survival of 12-5 months. In
4 patients with greater splenic enlargement the median survival was 3 months.
Adequate clinical information was not available in 13 patients. Other studies
(Hilton and Sutton, 1962) have indicated that clinical staging is helpful in prog-
nosis in Hodgkin's disease, but not in other types of lymphoma.
DISCUSSION
Manyattempts have been made to assesstheimportance ofvariousfactors upon
survival in Hodgkin's disease. Most ofthese series ofpatients have been derived
from the summation of the experience of a large hospital or clinic or from the
radiotherapy department of such institutions; such series are not unselected and
doubts can be expressed about the validity ofresults so derived. Selection factors
in hospital or clinic experience may include restriction of admission to or pre-
ference for certain age, social or racial groups, the presence at the hospital of
physicians specially interested in certain diseases, variation in the diagnostic and
radiotherapy facilities and attitudes and customs among local populations and
physicians. So long as it is not known what proportion of the total population
is admitted to these hospitals or clinics and on what basis the admissions are
arranged, statistics obtained from hospital records can be criticized on the grounds
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of case selection (Dameshek and Gunz, 1958). The way in which case selection
occurred differed in several reports. For example, Diamond (1958) reported the
experience of the Memorial Centre for cancer and allied diseases and found that
more than 50 per cent of the patients in his series were not only in an advanced
stage of the disease but also had received treatment in other institutions andby
other physicians. He noted that the services of the Memorial Centre had been
sought frequently as a last resort. Under such circumstances one would agree
that these factors would have a " depleting effect on overall end results " and it
is not unexpected that only 19-5 per cent of these patients survived for 5 years
from the time ofdiagnosis. On the other hand, itis extremely difficult to ascertain
what the results of such a study indicate. It is not possible to take a series such
as this and make some compensatory calculation by which the results can be
extrapolated to represent the findings in an unselected series of patients.
Paterson and Paterson (1954) found a crude 5-year survival of 25 per cent of
256 patients with Hodgkin's disease treated between 1934 and 1947 at the Christie
Hospital in Manchester; they reported an overall crude 5-year survival of 25
per cent. As this series was derived from the experience of a radiotherapy insti-
tute it is probable that the series included a high proportion of patients referred
for this form of management and so should be regarded as being selected. Many
other series of patients with Hodgkin's disease have been reported from radio-
therapy centres (Hilton and Sutton, 1962; Elkins, 1956; Peters, 1950).
The results reported by Peters (1960) may also be criticized from the standpoint
of case selection. The survival of 285 patients with Hodgkin's disease treated by
irradiation in Toronto between 1924 and 1954 were reported. Twenty patients
were treated in the period 1924 and 1934, and 60 per cent of these survived for 5
years. In the 5-year period between 1950 and 1954, however, 88 patients were
treated with a 5-year survival of 29 per cent. It is apparent that the number of
patients being treated has increased by almost 9 times while the survival shows a
decrease. It would seem logical to assume that with the larger number ofpatients
a more representative sampling ofthe disease is being obtained. The remarkable
survival in Peters' early series may be explained by case selection.
Cook, Krabbenhoft and Leucutia (1959) reported the results of treatment of
392 patients with Hodgkin's disease but excluded 45 patients who had received
no treatment. They analyzed the results of treatment in these 347 treated
patients and found that 34-6 per cent survived for more than 5 years from the
time of diagnosis. The fact that they excluded patients from the analysis of
survival is again evidence of case selection. One might with justification pre-
sume that it these exclusions had not been made the overall survival would not
have been as long as that reported. Criticism on the grounds of case selection
can be made of many other reported series.
The interpretation of the histopathologist may greatly affect the survival of a
series ofpatients diagnosed ashavingHodgkin'sdiseaseandconstitutesyetanother
means by which selection of cases may occur. In those cases where difficulty is
experienced in differentiating between hyperplastic conditions and Hodgkin's
disease if any bias towards a diagnosis of Hodgkin's disease occurs, such a series
subsequently will show extended survival. Review of the histopathology of all
patients with Hodgkin's disease who live for more than 5 years and especially
ifthey have shown no further evidence ofdisease, is highly desirable. Differences
in classification of the malignant lymphoid tumours may vary the composition
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of series of patients diagnosed as Hodgkin's disease. Comparability
between
series may thus be lost.
For these reasons it is difficult or even impossible to make a valid comparative
analysis of the results of treatment in Hodgkin's disease at different centres.
Even if one ignores factors of selection one finds that survival is measured
by
some from the date ofdiagnosis (Videbaek, 1950) and by others from the time
of
onset of symptoms (Hohl, Sarasin and Bessler, 1951). It would seem advisable
that in future studies survival be measured from the time of diagnosis. This is at
least a definite date. Often the onset of symptoms of Hodgkin's disease
is
insidious and patients may have difficulty in estimating their duration accurately.
Many patients "round off" the duration of the symptoms into such periods as
one, three, six or nine months or one year, but rarely do they estimate the inter-
vening periods. It is less accurate to measure survival from the time of onset
of symptoms than from the time of diagnosis. As each method of expressing
survival measures different features, it would also seem to be advisable to express
survival as the mode, the median, the mean (taking cognizance of the problem
of those patients still alive), the percentage surviving for 5 years and the time
survival graph methods for each series of patients.
Other absolute 5-yearsurvivalfiguresreported recently include 19f3 per cent
(Bethell,Andrews,NelighandMeyers, 1951),32 1 percent(Hohl,Sarasin, Bessler,
1951), 32-6 per cent(Kaplan andAllen, 1952), 25 per cent (Nice and Stenstrom,
1954; Elkins, 1956),18-6percent(Shimkin, Oppermann, Bostick and Low-Beer,
1955),and31percent(HiltonandSutton,1962). Inthisseries32percentsurvived
for 5 years but asalreadyindicated comparative analysis is of dubious validity.
Theeffectofanytreatment onthesurvivalofpatientswithHodgkin's disease
is extremely difficult to assess. In this series the general principles governing
treatment ofpatients withHodgkin's disease have remained unchanged during
the period under study. Radical radiation therapy has been given to those
patients withstage1 diseaseandto somepatientswith stage 2 disease where the
glandularinvolvement waslimitedtoadjacent areas. Patients with widespread
stage 2 disease and allpatients with stage 3 disease had treatment with chemo-
therapy,radiotherapy orboth. Themajorityofpatientsin stage 3 had nitrogen
mustard asprimarytreatment. Adrenalsteroidswereusedespeciallyinpatients
with anaemia. Manypatients, especially in the terminal stages oftheir illness,
received amultiplicityoftherapeuticagents, sometimessingly, andsometimes in
combination. If any response to treatment was obtained under these circum-
stances, it was possible only to guess which agent had been responsible and it
was notpossible to exclude the occurrence of anatural remission to explain the
improvement.
While the clinical course ofHodgkin's disease is usually progressive with a
fataltermination,theremaybeveryconsiderablevariationintherate ofprogress
when one patient is compared with another. There may be similar variation
howeverinthesamepatientatdifferenttimes. Naturalremissionsandvariation
in the rapidity ofprogress ofthe disease occur and often are unassociated with
treatment. Claimsthattherapyhasbeenresponsibleforimprovement, therefore,
have to bemadewithcaution. Anyattempttoanalyzetheeffect of aparticular
form of treatment on the duration of survival in Hodgkin's disease must take
cognizance ofthe fact that two factors are operative-the biological activity of
the disease and the effect of treatment. Frequently these factors cannot be
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separated although in those patients with Hodgkin's paragranuloma the histo-
logical appearances may give an indication of the improved prognosis by virtue of
the less active form of the disease.
From this series ofpatients it is difficult to draw firm conclusions. The results
ofShimkin et al. (1955) and of Hohl et al. (1951) however, show significant differ-
ences between the duration of the illness in females and males, females surviving
for longer periods of time. While our results show this difference it is not signifi-
cant statistically. Our results suggest that while this difference may be present
in younger females and males the pattern of difference is reversed after the age of
45 and that older females survive for shorter periods than older males. As
Shimkin has suggested, it would be interesting to carry out a clinical study on the
effect of hormone therapy in an attempt to prolong survival. Oestrogen therapy
for the post-menopausal female might be the most obvious first choice. When the
patient reaches the terminal stages of Hodgkin's disease we do not possess such a
wealth of effective therapeutic agents that would allow any factor of possible
benefit to be ignored. The assessment of the results of such a clinical trial,
however, would be extremely difficult.
It is to be hoped that new and better agents for the treatment of Hodgkin's
disease will be developed in the years to come. This hope, together with the
albeit relative successes obtained with present day management must support the
energetic employment of all means of treatment at our disposal in this disease.
With regard to philosophic considerations we would not presume to try to
improve upon the statement of Diamond (1958) who concluded his report: " In
no sphere of cancer medicine is there such an appallingly nihilistic philosophy
among physicians and surgeons, and even among radiologists, as there is in the
treatment of patients with malignant lymphomas. Yet we see swift and even
enthusiastic treatment by radical surgery ofcancers ofthe lung, pancreas, stomach,
soft parts, and bone, to name a few, whereas the total experience in terms of
five-year survival rates for all such patients hovers somewhat below 10 per cent!
Let us be critical of ourselves, of our present methods of treatment and of
our instructions to our colleagues and students and impart a dynamic philosophy
in treatment. Let us continue to search out the past experiences, the natural
history, and the vagaries of the biological activity of Hodgkin's disease while we
press forward in our search for better radiotherapeutic and chemotherapeutic
measures for this disease.
In the meantime, let us continue to prevail on our medical colleagues to
attempt diagnosis of Hodgkin's disease early, without temporization and guess-
work, so that the therapeutic means now available to us can be used forthwith and
to the best advantage of the patient ".
SUMMARY
One hundred and fiftv residents of the Province of Saskatchewan were founid
to have had Hodgkin's disease between 1946 and 1956 (inclusive). As all known
cases of Hodgkin's disease were collected from a clearly defined geographic area
during a specified period oftime, it is suggested that this series is unselected. The
methods by which the series was assembled are described together with the
unusual opportunities which exist in Saskatchewan for such a study.
The mean survival for patients in this series was 265 months and the meanl
survival 30 6 moniths. Thirty-two per cent survived 5 years from the time of
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diagnosis. The mode of survival was 0-3 months. Approximately one-third
of the patients died within one year after diagnosis, one-third survived for more
than one but less than five years, and one-third survived for five years or more.
As there is no universally accepted classification of malignant lymphoid
tumours it is probably that Hodgkin's disease is an ill-defined histopathological
entity. Selection of cases has occurred in a variety of ways in many of the
previously reported series of patients with Hodgkin's disease. For these reasons
it is suggested that comparative analysis between one reported series and another
is probably not valid.
The results of this series indicate that females survive for longer periods than
males. Survival was longer in the younger age groups. Endocrine factors may
be important in the survival ofpatients with Hodgkin's disease and for the elderly
female patient a clinical trial with oestrogens would appear to be justifiable.
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